Cairo – Mubasher: The board of directors of Ibnsina Pharma approved the appointment of Abdel Aziz Ali Abdel Aziz as a non-executive chairman and Mohamed Mohsen Mohamed Mahgoub as a vice chairman and CEO.

In addition, the board also named Mahmoud Abdel Gawad and Omar Abdel Gawad as managing directors, the company said in a bourse disclosure on Sunday.

The move is in line with the Financial Regulatory Authority’s (FRA) regulations to separate the positions of the chairman, the CEO, and the managing director.

In 2020, Ibnsina Pharma recorded net profits of EGP 224.66 million, down from EGP 328.77 million a year earlier, including minority shareholders’ rights.

Source: Mubasher

All Rights Reserved - Mubasher Info © 2005 - 2021 Provided by SyndiGate Media Inc. (Syndigate.info).

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.